First Nebraska Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Buy |
104,203
+122
| +0.1% | +$14.1K | 1.16% | 21 |
|
|
2025
Q4 | $11M | Sell |
104,081
-22
| -0% | -$2.06K | 1% | 25 |
|
|
2025
Q3 | $8.74M | Sell |
104,103
-2,500
| -2% | -$206K | 0.79% | 31 |
|
|
2025
Q2 | $8.42M | Buy |
106,603
+3,292
| +3% | +$262K | 0.81% | 30 |
|
|
2025
Q1 | $9.27M | Buy |
103,311
+3,142
| +3% | +$293K | 0.92% | 30 |
|
|
2024
Q4 | $9.96M | Buy |
100,169
+6,298
| +7% | +$649K | 0.96% | 25 |
|
|
2024
Q3 | $10.7M | Sell |
93,871
-1,019
| -1% | -$121K | 1.04% | 23 |
|
|
2024
Q2 | $11.7M | Sell |
94,890
-425
| -0.4% | -$54.7K | 1.21% | 18 |
|
|
2024
Q1 | $12.6M | Sell |
95,315
-847
| -0.9% | -$104K | 1.3% | 18 |
|
|
2023
Q4 | $10.5M | Buy |
96,162
+2,055
| +2% | +$213K | 1.21% | 18 |
|
|
2023
Q3 | $9.69M | Buy |
94,107
+431
| +0.5% | +$46.5K | 1.2% | 20 |
|
|
2023
Q2 | $10.8M | Sell |
93,676
-529
| -0.6% | -$60.1K | 1.29% | 17 |
|
|
2023
Q1 | $10M | Sell |
94,205
-345
| -0.4% | -$37.2K | 1.26% | 18 |
|
|
2022
Q4 | $10.5M | Sell |
94,550
-1,048
| -1% | -$107K | 1.37% | 16 |
|
|
2022
Q3 | $8.23M | Buy |
95,598
+1,027
| +1% | +$91.7K | 1.18% | 19 |
|
|
2022
Q2 | $8.62M | Sell |
94,571
-480
| -0.5% | -$42.6K | 1.13% | 20 |
|
|
2022
Q1 | $7.8M | Buy |
95,051
+3,440
| +4% | +$271K | 0.92% | 26 |
|
|
2021
Q4 | $7.02M | Buy |
91,611
+2,533
| +3% | +$202K | 0.84% | 29 |
|
|
2021
Q3 | $6.69M | Buy |
89,078
+2,255
| +3% | +$172K | 0.88% | 29 |
|
|
2021
Q2 | $6.75M | Sell |
86,823
-1,888
| -2% | -$140K | 0.88% | 28 |
|
|
2021
Q1 | $6.53M | Buy |
88,711
+6,528
| +8% | +$482K | 0.88% | 27 |
|
|
2020
Q4 | $6.41M | Sell |
82,183
-647
| -0.8% | -$49.5K | 0.93% | 25 |
|
|
2020
Q3 | $6.56M | Sell |
82,830
-1,542
| -2% | -$121K | 1.12% | 24 |
|
|
2020
Q2 | $6.23M | Buy |
84,372
+3,343
| +4% | +$252K | 1.15% | 20 |
|
|
2020
Q1 | $5.95M | Sell |
81,029
-1,497
| -2% | -$118K | 1.31% | 20 |
|
|
2019
Q4 | $7.16M | Buy |
82,526
+53
| +0.1% | +$4.35K | 1.16% | 22 |
|
|
2019
Q3 | $6.62M | Sell |
82,473
-821
| -1% | -$65.8K | 1.1% | 22 |
|
|
2019
Q2 | $6.66M | Sell |
83,294
-2,731
| -3% | -$209K | 1.16% | 22 |
|
|
2019
Q1 | $6.83M | Sell |
86,025
-35
| -0% | -$2.62K | 1.23% | 20 |
|
|
2018
Q4 | $6.27M | Sell |
86,060
-888
| -1% | -$62.7K | 1.27% | 19 |
|
|
2018
Q3 | $5.89M | Sell |
86,948
-1,072
| -1% | -$68.3K | 1% | 23 |
|
|
2018
Q2 | $5.1M | Buy |
88,020
+2,882
| +3% | +$163K | 1.09% | 25 |
|
|
2018
Q1 | $4.43M | Buy |
85,138
+14,015
| +20% | +$757K | 0.88% | 28 |
|
|
2017
Q4 | $3.82M | Buy |
71,123
+20,885
| +42% | +$1.16M | 0.78% | 30 |
|
|
2017
Q3 | $3.07M | Buy |
50,238
+94
| +0.2% | +$5.7K | 0.67% | 38 |
|
|
2017
Q2 | $3.07M | Buy |
50,144
+1,054
| +2% | +$64.2K | 0.69% | 39 |
|
|
2017
Q1 | $2.98M | Buy |
49,090
+2,360
| +5% | +$143K | 0.67% | 40 |
|
|
2016
Q4 | $2.63M | Sell |
46,730
-208
| -0.4% | -$12.2K | 0.63% | 40 |
|
|
2016
Q3 | $2.8M | Sell |
46,938
-378
| -0.8% | -$22.1K | 0.72% | 38 |
|
|
2016
Q2 | $2.6M | Buy |
47,316
+652
| +1% | +$34.7K | 0.68% | 40 |
|
|
2016
Q1 | $2.36M | Sell |
46,664
-167
| -0.4% | -$8.18K | 0.65% | 39 |
|
|
2015
Q4 | $2.36M | Sell |
46,831
-2,389
| -5% | -$120K | 0.71% | 36 |
|
|
2015
Q3 | $2.32M | Buy |
49,220
+220
| +0.4% | +$11.7K | 0.74% | 36 |
|
|
2015
Q2 | $2.66M | Sell |
49,000
-577
| -1% | -$32.4K | 0.81% | 36 |
|
|
2015
Q1 | $2.72M | Hold |
49,577
| – | – | 0.8% | 37 |
|
|
2014
Q4 | $2.69M | Sell |
49,577
-2,938
| -6% | -$164K | 0.78% | 35 |
|
|
2014
Q3 | $2.97M | Sell |
52,515
-629
| -1% | -$35.3K | 0.85% | 35 |
|
|
2014
Q2 | $2.93M | Sell |
53,144
-17,580
| -25% | -$959K | 0.84% | 36 |
|
|
2014
Q1 | $3.83M | Sell |
70,724
-7,396
| -9% | -$383K | 1.18% | 31 |
|
|
2013
Q4 | $3.73M | Sell |
78,120
-80
| -0.1% | -$3.66K | 1.17% | 27 |
|
|
2013
Q3 | $3.55M | Buy |
+78,200
| New | +$3.57M | 1.23% | 25 |
|
Other funds holding MRK
VCM
VPM
First Nebraska Trust's MRK Position: Q1 2026 in Review
First Nebraska Trust increased its Merck (MRK) stake by 0.12% in Q1 2026, buying an estimated $14.1K and bringing the position to 104,203 shares worth $12.5M. The position accounts for 1.16% of the portfolio, ranked #21.
First Nebraska Trust first reported a position in MRK in Q3 2013 and has held it in 51 quarters since. The position peaked at $12.6M in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- First Nebraska Trust held 104,203 shares of Merck worth $12.5M as of Q1 2026.
- First Nebraska Trust bought 122 Merck shares in Q1 2026, an estimated $14.1K.
- Merck made up 1.16% of First Nebraska Trust's portfolio in Q1 2026, its #21 holding.
- First Nebraska Trust first reported a position in Merck in Q3 2013 and has held it in 51 quarters since.
- First Nebraska Trust's Merck position peaked at $12.6M in Q1 2024.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.